Sean Williams
TMFUltraLong
Sean Williams is a data-driven Motley Fool contributing analyst who's been investing for 26 years and has penned north of 15,000 articles. You'll find him at the intersection of politics and investing tackling macroeconomic topics of interest (Social Security and Donald Trump's economic/tax policies), analyzing which stocks billionaire investors (e.g., Warren Buffett) are buying and selling, and digging into how the world's most-influential businesses and trends -- everything from the evolution of artificial intelligence (AI) to the next stock split -- are changing Wall Street. He holds a B.A. in Economics from the University of California, San Diego.
Recent Articles by Sean Williams
Oct 7, 2014
by Sean Williams
Cheap Stocks Wall Street Loves: NPS Pharmaceuticals, Inc.
NPS Pharmaceuticals' stock is up nearly 150% over the trailing two-year period, yet it's still considered a cheap stock by Wall Street's standards. Find out why Wall Street is so in love with this company and whether its share price can head even higher.
Oct 6, 2014
by Sean Williams
Cheap Stocks Wall Street Loves: Smith & Wesson
Smith & Wesson has misfired in a big way over the past couple of months, but that hasn't changed Wall Street's tune one iota. Find out why the Street loves this cheap stock and whether or not that love translates into a tangible reason to buy Smith & Wesson
Oct 6, 2014
by Sean Williams
Better Dividend Stock: Visa Inc. or MasterCard Inc.?
Dividend stocks are a dime a dozen, but it takes some digging beyond the surface to uncover truly great dividends. Today we'll pit payment processors Visa and MasterCard against one another to determine which is truly the better dividend stock.
Oct 6, 2014
by Sean Williams
Cheap Stocks Wall Street Loves: Medivation
Medivation stock is up more than 1,000% over the past three years and yet is still considered a cheap stock when using this Wall Street metric. Find out why Wall Street has fallen in love with Medivation, and whether or not the stock can head higher.
Oct 6, 2014
by Sean Williams
Better Dividend Stock: Amgen, Inc. or AbbVie Inc.?
Investing in dividend stocks might appear easy, but not all dividends are really pulling their weight. After biopharmaceutical giants Amgen and AbbVie face off, find out which company is really the better dividend stock for investors.
Oct 5, 2014
by Sean Williams
5 States Expected to See the Biggest Increase in Alzheimer's Disease
Alzheimer's disease affects one in nine people age 65 and up, and is expected to be diagnosed in 13.8 million people in the U.S. by 2050. Find out which states are expected to see the biggest increase in diagnoses over the next decade, as well as what's being done to help fight this terrible disease.
Mar 7, 2017
by Sean Williams
The Average Joe's Guide to Financial Security
Average household income for the average American has risen by nearly 4% since 2011, but that doesn't mean we have a lot of disposable income to work with. Find out five simple things the average Joe can do to ensure their financial security well into their golden years.
Oct 5, 2014
by Sean Williams
Obamacare Enrollment: Too Complicated for Its Own Good?
Open enrollment for Obamacare will kick off in about six weeks, but things may not go as smoothly as you'd expect. Find out what complications could have insurers struggling to add to their enrollment figures from 2014.
Oct 4, 2014
by Sean Williams
Better Dividend Stock: Merck & Co. Inc. or Bristol-Myers Squibb Co.?
S&P 500 companies paid out $91.5 billion in dividends last quarter. Unfortunately, not all dividend stocks are created equally. Let's examine two of Big Pharma's highest-yielding stocks to determine which is the better dividend stock.
Oct 4, 2014
by Sean Williams
Better Dividend Stock: GlaxoSmithKline PLC or AstraZeneca PLC?
U.K.-based Big Pharma stocks GlaxoSmithKline and AstraZeneca have some of the juiciest dividends within the healthcare sector; but how sustainable are these yields? Find out which of these two is the better dividend stock.
Oct 4, 2014
by Sean Williams
Lung Cancer Incidence Is the Highest in These 10 States
Lung cancer is estimated to have claimed 160,000 lives in the U.S. in 2013, and it's particularly common in these 10 states. Find out what's being done to improve patients' quality of life and overall survival in lieu of this terrible disease.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.